Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 21, 2008
- Accepted June 12, 2008
- Published online August 18, 2008.
Article Versions
- Earlier version (June 13, 2008 - 10:45).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Keiichi Kuwano,
- Asami Hashino,
- Kumiko Noda,
- Keiji Kosugi and
- Kenji Kuwabara
- Address correspondence to:
Dr. Keiichi Kuwano, Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 14 Nishinosho-Monguchi-Cho, Kisshoin, Minami-Ku, Kyoto 601-8550, Japan. E-mail: k.kuwano{at}po.nippon-shinyaku.co.jp
Statistics from Altmetric.com
Article usage
In this issue
A Long-Acting and Highly Selective Prostacyclin Receptor Agonist Prodrug, 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), Ameliorates Rat Pulmonary Hypertension with Unique Relaxant Responses of Its Active Form, {4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}acetic Acid (MRE-269), on Rat Pulmonary Artery
